FORMA Therapeutics, Inc. Appoints Christopher Dinsmore To Vice President, Medicinal And Computational Chemistry
Published: Jan 07, 2014
FORMA Therapeutics announced today that Christopher Dinsmore, Ph.D., has been appointed to the position of Vice President, Medicinal and Computational Chemistry. Dr. Dinsmore joins FORMA after a distinguished 19 year career at Merck & Co. Inc., where he helped build the Merck Research Laboratory in Boston.
Help employers find you! Check out all the jobs and post your resume.